NAV

NomeCodice ISINDivisaDataNAV 
J.LAMARCK BIOTECH Class ALU0574993464EUR23/02/2017325,30
J.LAMARCK BIOTECH Class BLU0574994512EUR23/02/2017306,57
J.Lamarck Biotech - Class CLU1053929581USD23/02/2017329,27
ICAM First Class A*LU1184118112EUR06/05/2015NA
ICAM First Class BLU1184130240EUR17/02/2017100,05
CRYSTAL Blue Fund Class ALU1209869376EUR23/02/201795,23
CRYSTAL Blue Fund Class BLU1209869533EUR23/02/201793,98
CRYSTAL Rose Fund Class ALU1209869707EUR23/02/201793,28
CRYSTAL Rose Fund Class BLU1209869962EUR23/02/201791,89
J Lamarck Pharma - Class ALU1224032034EUR23/02/201789,09
J.Lamarck Biotech - Class DLU1246176264EUR23/02/2017106,18
J Lamarck Pharma - Class DLU1246176850EUR23/02/201791,52
CRYSTAL Blue Fund Class DLU1246178047EUR23/02/201797,63
CRYSTAL Rose Fund Class DLU1246179102EUR23/02/201796,09

* non lanciato

Disclaimer

The information and opinions concerning funds and subfunds accessed through this link are not intended for consultation in those jurisdictions where these funds and subfunds are not registered or are otherwise unauthorised.

No information or opinion accessed through this link constitutes a solicitation, offer or recommendation to buy, sell or otherwise dispose of any investment, to engage in any other transaction or to furnish any investment advice or services.

Potential subscribers are advised to seek professional advice on the laws and regulations applicable to the subscription, purchase, holding, redemption and sale of shares in their countries of citizenship, residence or domicile.

No responsibility or liability is accepted regarding the accuracy, reliability or legality of any information whatsoever accessed through this site, or in respect of the contents of any website linked to the current site.

Past performance is not a guarantee of future returns. The value of investments may fall as well as rise.

Investors are expressly informed that this site provides information only, and that investment decisions should be made based on a full reading of the fund prospectus and the most recent financial statements.

Selecting the country of your residence will accept the conditions: